Pharmacokinetics of Preoperative Vancomycin

NCT03453684 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-05-24

Study results available
· View outcomes & findings →

Summary

A study of plasma and tissue vancomycin pharmacokinetics in pediatric surgical patients.

Conditions

  • Surgical Site Infection
  • Vancomycin

Interventions

DRUG

Administration of Vancomycin

Intravenous Vancomycin Administration

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Melissa Brooks-Peterson, MD · University of Colorado, Denver

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
31 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-01
Primary Completion
2013-06-30
Completion
2015-07-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03453684 on ClinicalTrials.gov